IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#2804
Positioning
Market Dominance
Services
Computer Software
$56M
Robert P. LoCascio
LivePerson, Inc., together with its subsidiaries, provides conversational commerce software and Gainshare solutions. The company offers the Conversational Cloud, an enterprise-class and cloud-based platform. It also provides professional services and value-added business consulting services.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = LPSN ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | 21.3% | 18.6% | 64.5% | 35.7% | 39.5% | 6.5% | 0.0% | 0.0x | $644M | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | 15.4% | 12.6% | 38.7% | 17.1% | 17.0% | -39.7% | 0.0% | 0.0x | $439M | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 28.1% | 16.8% | 48.1% | 23.8% | 18.5% | 78.6% | 0.0% | 37.0x | $220M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | 12.4% | 2.9% | 100.0% | 28.2% | 26.2% | 5.5% | 0.8% | 264.0x | $19.4B | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.6% | 7.8% | 43.8% | 7.4% | 5.9% | 31.2% | 0.0% | 0.0x | $857M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 18.0% | 4.6% | 97.3% | 52.2% | 32.7% | -3.4% | 0.0% | 271.0x | $8.0B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | 9.4% | 4.9% | 55.5% | 8.7% | 7.7% | 13.6% | 1.3% | 7.0x | $78.0B | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | 22.1% | 15.6% | 62.5% | 28.1% | 28.7% | -1.0% | 2.8% | 9.0x | $56.6B | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 21.4% | 8.0% | 100.0% | 10.0% | 7.5% | 14.1% | 0.0% | 27.0x | $1.8B | VS | |
$LPSN LIVEPERSON INC | 45 | 33 | 50 | 78 | 2.7x | - | -166.7% | -9.7% | 70.0% | -20.7% | -18.0% | -24.7% | 0.0% | - | $56M | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.3% | 1.9% | 59.6% | 3.5% | 2.3% | 7.8% | 0.0% | 0.3x | - | REF |
LIVEPERSON INC (LPSN) receives a "Reduce" rating with a composite score of 45.0/100. It ranks #2804 out of 7,333 stocks in our coverage universe and carries a 2-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Direct cash return
Robert P. LoCascio
Chief Executive Officer
Labor Force
1,540
33
35
15
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for LPSN
Outperforming peers — winners tend to keep winning over 3-12 months
Fair valuation relative to peers
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for LPSN.
View All RatingsConservative accounting — High cash conversion efficiency
Material decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 33 | 22 | +11ALPHA |
| MOMENTUM | 78 | 87 | -9DRAG |
| VALUATION | 50 | 53 | -3NEUTRAL |
| INVESTMENT | 35 | 54 | -19DRAG |
| STABILITY | 15 | 7 | +8ALPHA |
| SHORT INT | 33 | 22 | +11ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC -4.2% vs WACC 4.4% (spread -8.6%)
GM 70% vs sector 60%, OM -21% vs sector 4%
Capital turnover 0.22x, R&D intensity 23.4%
Rev growth -25%, 10yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
LIVEPERSON INC receives a Reduce rating from our analysis, with a composite score of 45.0/100 and 2 out of 5 stars, ranking #2804 out of 7,333 stocks. LPSN's factor profile shows weakness across multiple dimensions, suggesting the stock may underperform going forward. Existing holders may want to consider trimming positions or tightening stop-losses.
LPSN's quality score of 33/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -166.7% (sector avg: 5.3%), gross margins of 70.0% (sector avg: 59.6%), net margins of -18.0% (sector avg: 2.3%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
LPSN's value score of 50/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 2.73x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
LIVEPERSON INC's investment score of 35/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -24.7% vs. a sector average of 7.8% and a return on assets of -9.7% (sector: 1.9%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
LPSN shows strong momentum characteristics with a score of 78/100. The stock has been trending above key moving averages, indicating solid demand from institutional buyers. Revenue growth stands at -24.7% year-over-year, while a beta of 7.08 reflects its sensitivity to broader market moves. This level of momentum typically signals sustained investor confidence and favorable near-term price action.
LIVEPERSON INC registers a low stability score of 15/100, indicating high volatility and potentially stressed financial conditions. Key stability metrics include a beta of 7.08. Stocks at this level carry elevated capital loss risk and may be unsuitable for conservative portfolios without careful risk management.
LIVEPERSON INC's short interest score of 33/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include high market sensitivity (beta: 7.08), micro-cap liquidity risk. At $56M (micro-cap), LPSN carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
LIVEPERSON INC is a micro-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #2804 of 7,333 overall (62nd percentile). Key comparisons include ROE of -166.7% trailing the 5.3% sector median and operating margins of -20.7% below the 3.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While LPSN currently exhibits a REDUCE profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Stability (15) would have the largest impact on the composite score.
ROE 3240% BELOW SECTOR MEDIAN
Gross Margin 17% ABOVE SECTOR MEDIAN (FAVORABLE)
Op. Margin 690% BELOW SECTOR MEDIAN
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate LIVEPERSON INC (LPSN) as a Reduce with a composite score of 45.0/100 at a current price of $2.73. The quantitative profile shows weakness across multiple dimensions, suggesting limited upside potential and elevated risk of underperformance relative to peers over the next 12 months.
The rating is primarily driven by strength in momentum (78th percentile) and value (50th percentile), which together account for the majority of the composite score. Offsetting weakness in stability (15th percentile) and quality (33th percentile) tempers our overall conviction. We assign a No Moat rating (25/100), Very High uncertainty, and Poor capital allocation.
Key items to watch: whether strong momentum is fundamentally supported by revenue trends; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
LIVEPERSON INC holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 45.0/100 places it at rank #2804 in our full 7,333-stock universe. At $56M in market capitalization, LIVEPERSON INC is a small-cap player in the Services space, which limits certain scale advantages but may allow for more agile strategic execution.
Despite positive momentum (78th percentile), revenue contraction of -25% creates a divergence between price action and fundamental trajectory. This divergence suggests either that the market is looking through near-term weakness or that technical factors are temporarily inflating the stock. Investors should assess whether the revenue decline reflects cyclical weakness or structural challenges.
The margin cascade tells an important story: gross margins of 70% (+10.4pp vs sector) narrow to operating margins of -21% (-24.2pp vs sector) and net margins of -18.0%, yielding a gross-to-net conversion rate of -26%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $2.73, LIVEPERSON INC is trading near fair value based on current fundamentals. Our value factor score of 50/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at a P/E of 2.7x (a 89% discount to the sector median of 23.7x), P/S of 0.1x. The below-sector P/E suggests possible undervaluation or the market pricing in near-term headwinds.
Gross margins of 70% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Positive momentum (78th percentile) indicates institutional accumulation and favorable technical dynamics that tend to persist in the intermediate term.
The Reduce rating (composite 45.0/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Revenue decline of -25% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
Thin net margins of -18.0% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
We assign a Very High uncertainty rating to LIVEPERSON INC. The stock exhibits multiple compounding risk factors: elevated market sensitivity (beta of 7.08), current negative profitability (net margin -18.0%), below-average price stability (15th percentile). The extreme uncertainty around future cash flows makes precise valuation difficult, and the range of outcomes is exceptionally wide. Only investors with high risk tolerance and extended time horizons should consider this name.
Specific risk factors that inform our assessment include: elevated market sensitivity (beta of 7.08); current negative profitability (net margin -18.0%); below-average price stability (15th percentile); weak quality scores (33th percentile). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 15th percentile and quality factor at the 33th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 70% provide a buffer against cost pressures. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile warrants caution and disciplined position management.
We rate LIVEPERSON INC's capital allocation as Poor. Key concerns include low returns on equity (-166.7%), negative profitability, weak asset returns (ROA -9.7%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — LIVEPERSON INC significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, LIVEPERSON INC receives a Reduce rating with a composite score of 45.0/100 (rank #2804 of 7,333). Our quantitative framework assigns a No Moat (25/100, trend: stable), Very High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 42/100.
Our analysis does not support a constructive view on LIVEPERSON INC at this time. The combination of limited competitive advantages, very high uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign LIVEPERSON INC a meaningful economic moat, scoring 25/100 on our composite assessment. The ROIC-WACC spread of -8.6% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 11/20.
The strongest moat sources are margin superiority (11/20) and reinvestment efficiency (7/20). GM 70% vs sector 60%, OM -21% vs sector 4%. Capital turnover 0.22x, R&D intensity 23.4%. These pillars form the core of LIVEPERSON INC's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include economic value creation (1.2/20) and financial resilience (2.1/20). ROIC -4.2% vs WACC 4.4% (spread -8.6%). Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect LIVEPERSON INC's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 70% providing a solid profitability foundation, declining revenues (-25%) that pressure the earnings outlook. The margin cascade from 70% gross to -21% operating to -18.0% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality raises some durability concerns, with the quality factor at the 33th percentile.
The margin profile shows gross margins of 70%, operating margins of -21%, net margins of -18.0%. Return metrics include ROE of -166.7% and ROA of -9.7%. Relative to the Services sector, gross margins are 10.4 percentage points above the sector median of 60%, and ROE of -166.7% compares to a sector median of 5.3%.
The balance sheet reflects revenue growth of -25%. Overall balance sheet health is adequate for the current business environment.
Below-average quality (33th percentile) raises durability concerns about the fundamental profile and increases the risk of negative earnings surprises.
High beta of 7.08 means amplified losses in market selloffs — in a broad market correction, this stock would likely decline more than the index.
Above 50MA
37.18%
Net New Highs
+51081

U.S. stock futures fell on Tuesday after the Senate passed a resolution to reopen the government. Market attention was focused on several company earnings reports and potential Federal Reserve interest rate cuts.
Unfortunately for some shareholders, the LivePerson, Inc. ( NASDAQ:LPSN ) share price has dived 31% in the last thirty...

U.S. stocks traded mixed toward the end of trading, with the S&P 500 gaining around 0.3% on Thursday. The Dow traded down 0.08% to 38,919.26 while the NASDAQ rose 0.53% to 16,032.35. The S&P 500 also rose, gaining, 0.30% to 5,084.84. Check This Out: Robinhood, Shake Shack And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Real estate shares rose by 1.2% on Thursday. In trading on Thursday, health care shares fell by 0.6%. Top Headline Shares of Hayward Holdings, Inc. (NYSE: HAYW) surged over 17% on Thursday after the company reported better-than-expected fourth-quarter results. Hayward Holdings posted adjusted earnings of 20 cents per share, beating market estimates of 18 cents per share. The company’s quarterly sales came in at $278.47 million versus expectations of $271.92 million. Equities Trading UP Societal CDMO, Inc. (NASDAQ: SCTL) shares shot up 130% to $1.06. Privately held CoreRx Inc. will acquire Societal CDMO, a contract development and manufacturing organization. Shares of Enveric Biosciences, Inc. (NASDAQ: ENVB) got a boost, surging 125% to $1.87. Enveric Biosciences signed a non-binding term sheets to pursue the exclusive out-licensing of three classes of compounds. Vertex, Inc. (NASDAQ: ...

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Butterfly Network posted GAAP loss of 21 cents per share versus market estimates for a loss of 14 cents per share. The company’s quarterly sales came in at sales came in $16.52 million versus estimates of $15.35 million. Butterfly Network shares dipped 21.7% to $1.1588 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Enveric Biosciences, Inc. (NASDAQ: ENVB) gained 177.1% to $2.30 after the company announced it has signed three non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of compounds. Societal CDMO, Inc. (NASDAQ: SCTL) shares climbed 132.7% to $1.07 as the company agreed to be acquired by CoreRx, Inc. Volcon, Inc. (NASDAQ: VLCN) gained 55.4% to $1.8802 after surging around 39% on Wednesday. Sidus Space, Inc. (NASDAQ: SIDU) climbed 39.7% to $7.78. Ocean Biomedical, Inc. (NASDAQ: OCEA) gained 36.4% to $2.1008. Ocean Biomedical announced joint venture partner, Virion Therapeutics to present clinical study data at 2024 APASL Global Liver Meeting. Inseego Corp. (NASDAQ: INSG) rose 34.5% to $3.00. Vertex, Inc. (NASDAQ: VERX) jumped 29.8% to $32.97 after the company reported better-than-expected fourth-quarter results and issued strong FY24 guidance. iHeartMedia, Inc. (NASDAQ: IHRT) rose 29.1% to $2.93 following fourth-quarter results. Agrify Corporation (NASDAQ: AGFY) gained 27% to $0.6161. Agrify announced a $3.4 million sales order from New Jersey woman-owned business HarvestWorks Farm. Renalytix Plc (NASDAQ: RNLX) climbed 26.5% to $1.05 after the company announced that effective Mar. 1, the US approved adding the company's kidneyintelX.dkd to its 10-year Governmentwide Acquisition Contract. Tutor Perini Corporation (NYSE: TPC) gained 26% to $11.64 following fourth-quarter results. Bright Scholar Education Holdings Limited (NYSE: BEDU) gained 25.3% to $2.3178. C3.ai, Inc. (NYSE: AI) shares rose 24.6% to $37.00 after the company reported better-than-expected third-quarter financial results. Sterling Check Corp. (NASDAQ: STER) jumped 24.6% to $15.49 after the company agreed to be acquired by First Advantage for approximately $2.2 billion, including outstanding debt. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) gained 24% to $2.00. Adial Pharmaceuticals was awarded a new patent covering AD04 for the potential treatment of opioid use disorder. Revance Therapeutics, Inc. (NASDAQ: RVNC) jumped 24% to $7.02 after the company reported better-than-expected quarterly financial results. Latham Group, Inc. (NASDAQ: SWIM) climbed 22.8% to $3.36. Avidity Biosciences, Inc. (NASDAQ: RNA) jumped 22.5% to $18.70. Avidity Biosciences announced an oversubscribed $400 million private placement. Pure Storage, Inc. (NYSE: PSTG) rose 21.9% to $51.35 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter revenue guidance above estimates. ...
NEW YORK, February 02, 2026--Better Home & Finance Holding Company (NASDAQ: BETR; BETRW) ("Better" or the "Company"), the leading AI-native home finance company and the first fintech to fund more than $110 billion in loan volume, welcomes Loveen Advani as Better’s Chief Financial Officer, effective today.